Appointment

Suspendisse interdum consectetur libero id. Fermentum leo vel orci porta non. Euismod viverra nibh cras pulvinar suspen.

Dr. Nikhil Himthani

Home / Doctor / Dr. Nikhil Himthani

Dr. Nikhil Himthani is a medical oncologist with 10 years of experience in the field of oncology. Graduated from GMC Haldwani, MD from IGMC Shimla, and DM in Medical Oncology and Hemato-Oncology from the renowned GCRI. Previous collaboration with Max Hospital Saket and Action Cancer Hospital, Paschim Vihar. He is well trained and experienced in the treatment of all solid and hematologic malignancies in adult and pediatric patients with a strong interest in immunotherapy and breast cancer.

  • Designation: Consultant
  • Department : Medical Oncology and Hemato-Oncology

Area of Interest 

  • Breast cancer
  • Head and neck cancer
  • Lung cancer
  • Multiple myeloma
  • Lymphoma
  • Acute and chronic leukemia
  • Prostate cancer
  • Sarcomas
  • Brain tumor
  • Bone tumors
  • Gastrointestinal cancer
  • Gynecological cancer
  • Genitourinary cancers

Education & Training 

  • Doctorate of Medicine, (DM)-Medical Oncology 2nd Rank Gujarat Cancer Research Institute Ahmedabad, India (August 2018-August 2021)
  • Doctor of Medicine (MD)-GOLD MEDALIST Indira Gandhi Medical College Shimla. (2013-2016)
  • Bachelor of Medicine and Bachelor of Surgery (MBBS) Government Medical College, Haldwani, Uttarakhand, India. (2007-2012)
  • Co-investigator in Clinical trial during DM residency. (ORION STUDY)
  • AROICON 2015, Delhi- First prize in paper presentation
  • AROICON 2015, Delhi-Second Prize in Quiz

 

Awards, Honours, & Memberships 

  • Extensive Use of Systemic Chemotherapy for Solid and Hematological Malignancies.
  • Extensive Use of Targeted Therapies Available in India.
  • Several immuno-oncology drugs are available in India.
  • Pain Management and Palliative support including end-of-life care.
  • Management of Oncological Emergencies and ICU care.
  • Oncological Procedures-Central Venous device (PORT/PICC/Central lines) handling, Lumbar Puncture, and Bone Marrow Biopsy.
  • Management of Chemotherapy toxicities, Monoclonal Antibodies, and Immunologic ADRs.
  • ISMPO ASCO ESMO.
  • Tocilizumab treatment and outcomes in severe COVID-19 patients: Retrospective Study from a tertiary care institute in western India. They were published in JMSR in December 2020.
  • Acute Leukemia in Pregnancy: Case series from a Tertiary Care Institute. Published in JMSR in April 2021.

Experience

  • Consultant-Medical Oncology, IOCI, ICI Hospital Greater Kailash Delhi 2024.
  • Consultant Medical Oncologist at Batra Hospital Delhi 2023.
  • Associate Consultant Medical Oncology at Action Cancer Hospital 2021-2023.
  • Senior Resident Max Hospital Saket 2016-2018.
Hi, I am online to help you!